Insmed Investing Cash Flow increased by 134.8% to $265.52M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 230.2%, from $80.41M to $265.52M.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$3.49M | -$8.40M | -$51.22M | -$101.41M | -$2.90M | $49.42M | $41.60M | -$274.16M | $7.15M | $0.00 | $295.32M | -$6.78M | -$1.00B | $80.41M | $227.84M | -$762.23M | $265.52M |
| QoQ Change | — | -141.1% | -509.7% | -98.0% | +97.1% | >999% | -15.8% | -759.0% | +102.6% | -100.0% | — | -102.3% | <-999% | +108.0% | +183.3% | -434.6% | +134.8% |
| YoY Change | — | — | — | — | +16.7% | +688.2% | +141.0% | <-999% | -85.5% | — | +609.9% | +97.5% | <-999% | -72.8% | >999% | +24.0% | +230.2% |